問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
余明隆
下載
2024-06-11 - 2030-12-31
Condition/Disease
Test Drug
Participate Sites5Sites
Not yet recruiting2Sites
Recruiting3Sites
2024-11-15 - 2032-04-30
Participate Sites3Sites
2025-01-01 - 2032-12-31
Participate Sites12Sites
Recruiting12Sites
2025-01-01 - 2030-01-31
Participate Sites11Sites
Recruiting11Sites
2024-12-01 - 2029-03-31
Participate Sites9Sites
Recruiting9Sites
2022-09-01 - 2025-03-07
Participate Sites4Sites
Recruiting4Sites
2022-02-16 - 2026-12-31
2022-06-01 - 2026-12-31
Participate Sites6Sites
Not yet recruiting1Sites
Recruiting5Sites
2020-09-01 - 2022-08-31
2018-06-01 - 2022-11-15
Advanced Malignancies
Isatuximab
Participate Sites7Sites
Division of Hematology & Oncology
未分科
全部
